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Abstract 
Acute lymphoblastic leukemia (ALL) is the most common type of cancer diagnosed in 
children. However, little is known about how socioeconomic status (SES) influences the 
outcomes of children diagnosed with ALL. The goal of the research study was to understand how 
SES impacted the outcomes of children diagnosed with ALL, with a particular interest in 
children living in West Michigan. Children ages 0-14 years who received treatment for ALL at 
Spectrum Health’s Helen DeVos Children’s Hospital’s Pediatric Hematology and Oncology 
program between the years 2002-2011 were considered for this study. Eligible participant’s zip 
codes and dates of relapse/death were obtained through retrospective chart reviews to investigate 
the association of interest. Zip codes were utilized to create neighborhood SES scores based on 
census data related to education, occupation, and household income. Time to relapse/death was 
determined to calculate five-year event-free survival. Differences in survival across 
socioeconomic tertiles were evaluated using Kaplan-Meier survival analysis, with Cox-
proportional hazard regression conducted to describe the association between all collected 
variables. Statistical analyses revealed that children of higher socioeconomic standing were 
shown to have an increased risk of relapse or death compared to children of lower 
socioeconomic standing, however these findings did not show a statistically significant 
difference between the neighborhood socioeconomic tertiles. Although previous research has 
shown that those of higher SES tend to have better overall health and better health outcomes, 
compared to those of lower SES, this research study suggests that these differences may not 
always occur as expected. Decreased exposure to early childhood infectious agents by way of 
improved hygiene and changes in childcare may explain why children of higher socioeconomic 
may be at greater risk of poor health outcomes compared to those of lower socioeconomic 
standing. These findings may also indicate that differences in outcomes between various 
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socioeconomic groups may have diminished over the period of interest through the use of better 
health communication and health services.  
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I. Introduction 
 
Leukemia is a form of blood/bone marrow cancer that affects people of all ages. While 
many types of leukemia exist within nature, children under the age of 15 years are more notably 
diagnosed with acute lymphoblastic leukemia (ALL), the most common type of cancer for this 
age group (United States Cancer Statistics Working Group, 2016). Between the years 2009-2013, 
the incidence rate for all leukemias in children ages 0-14 was 5.23 cases per 100,000 children 
(United States Cancer Statistics Working Group, 2016). Leukemias of lymphoid origin 
accounted for 4.00 of those cases (United States Cancer Statistics Working Group, 2016). A 
variety of risk factors for this disease exist, including genetic mutations and environmental 
exposures, however most patients do not have any of the known risk factors for leukemia 
(Hunger & Mullighan, 2015). Similarly, little is known about how some factors, such as 
socioeconomic status and race/ethnicity, influence patient outcomes among those that have been 
diagnosed with ALL. Lower socioeconomic status has been associated with worse outcomes for 
many health problems across the world, however its influence on the outcomes of those 
diagnosed with ALL is not well understood (Demakakos, Nazroo, Breeze, & Marmot, 2008). 
And although the association between socioeconomic status and ALL outcomes has been studied 
by other researchers, few studies have been conducted within the United States, with none 
looking specifically at a West Michigan population (Bona, Blonquist, Neuberg, Silverman, & 
Wolfe, 2016; Charalampopoulou et al., 2004; Erdmann et al., 2014; Gupta, Sutradhar, Guttmann, 
Sung, & Pole, 2014; Gupta, Wilejto, Pole, Guttmann, & Sung, 2014; Kent, Sender, Largent, & 
Anton-Culver, 2009; Lightfoot et al., 2012; Metzger et al., 2003; Njoku, Basta, Mann, McNally, 
& Pearce, 2013; Petridou et al., 2015; Sergentanis et al., 2013; Son, Kim, Oh, & Kawachi, 2011; 
Viana, Fernandes, de Carvalho, & Murao, 1998). 
13 
 
Purpose 
 The purpose of this research study is to determine if there is a difference in five-year 
event-free survival among West Michigan children diagnosed with ALL living in various 
socioeconomic standings.  
Scope 
 This study will be used to determine if there is a difference in event-free survival for 
children diagnosed with ALL among different socioeconomic groups studied. The study 
population will be defined as children receiving pediatric cancer care for ALL from Spectrum 
Health’s Helen DeVos Children’s Hospital’s Pediatric Hematology and Oncology program who 
live within a specific set of counties in West Michigan. For children diagnosed with ALL 
between January 1, 2002 and December 31, 2011 who meet the inclusion criteria stated above, 
demographic information, as well as leukocyte count at diagnosis, age at diagnosis, 
immunophenotype of the child’s cancer, and zip code will be collected via electronic medical 
record (EMR) review to assess for potential differences in survival based on neighborhood 
socioeconomic scores. 
Hypothesis 
 Null Hypothesis (H0): there is no difference in survival between those with lower 
socioeconomic status and those with higher socioeconomic status 
 Alternative Hypothesis (Ha): there is a difference in survival between those with lower 
socioeconomic status and those with higher socioeconomic status 
 Although the formal hypotheses are stated as being two-sided to allow for a difference in 
either direction, the researcher hypothesizes that there will be difference in survival by the level 
of socioeconomic status, with children of lower socioeconomic standing having worse outcomes 
compared to children of higher socioeconomic standing. People of higher socioeconomic 
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standing tend to have better overall health and better health outcomes, compared to those of 
lower socioeconomic standing (Demakakos et al., 2008). Among studies that looked at 
socioeconomic status’ influence on ALL outcomes within the United States, most of the studies 
found differences in survival between different socioeconomic groups, with those being of lower 
socioeconomic standing having worse ALL outcomes, further supporting the researcher’s 
hypothesis (Abrahão et al., 2015; Acharya et al., 2016; Kent et al., 2009). 
Significance 
Due to the previous establishment of socioeconomic status’ influence on health outcomes 
for a variety of health problems, it is imperative that individuals understand its impact on those 
diagnosed with ALL. As of 2016, Michigan ranked seventh within the United States for 
estimated new cases of leukemia with 1,890 possible new cases (Siegel, Miller, & Jemal, 2016). 
Michigan also ranked eighth within the United States for estimated deaths from leukemia, with 
850 possible deaths likely to have occurred in 2016 (Siegel et al., 2016). While this study will 
only look at those diagnosed with ALL within West Michigan, the understanding of this possible 
difference in survival among various socioeconomic groups can allow doctors and communities 
to tailor their accommodations for these cancer patients on a one-to-one basis. While treatment 
protocols typically remain the same for all pediatric patients diagnosed with ALL, physicians 
may be able to modify the types of conversations they are having with their various patients 
based on their socioeconomic status. 
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II. Literature Review 
 
 Acute lymphoblastic leukemia is known to have a variety of factors that can affect overall 
survival and event-free survival. Each case of ALL is unique due to a combination of these 
factors, which include leukocyte count at diagnosis, age at diagnosis, the patient and his or her 
family’s socioeconomic status, the patient’s primary form of medical insurance, the patient’s 
race and ethnicity, the immunophenotype and cytogenetics of the leukemic cells, and the sex of 
the patient (Alperstein, Boren, & McNeer, 2015; Lustosa de Sousa, de Almeida Ferreira, 
Cavalcante Félix, & de Oliveira Lopes, 2015; Teachey & Hunger, 2013). Many studies have 
been designed to understand how these various factors influence outcomes in children with ALL, 
however additional studies continue to be published due to the differences seen among different 
places within the United States and the world. Other potential predictive factors of outcome in 
ALL, such as the level of adherence to treatment therapy, the existence of a mediastinal mass, 
and central nervous system involvement, have also been studied but have limited research to 
confirm their predictive nature (Bhatia et al., 2012, 2014; Teachey & Hunger, 2013). 
Nevertheless, it is important that all factors are discussed in order to understand how each 
influence the outcome of the research question that will be studied. 
Purpose 
 While many factors for ALL have been identified, some factors have various effects in 
different parts of the world, namely socioeconomic status and form of health insurance. 
Socioeconomic status is a complex entity that can be influenced by a variety of factors, such as 
income, education, and occupation (Diez Roux et al., 2001). Socioeconomic status can also 
impact health insurance opportunities, potentially limiting treatment options for children with 
ALL. Thus, it is important that the effect of socioeconomic status is studied in various population 
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settings to determine how it affects children who are diagnosed with ALL. However, other 
factors also play an important role in the survival of children with ALL, therefore these 
predictive factors will also be included within the study’s analyses. All factors will be discussed 
to provide baseline knowledge of its known effects on children diagnosed with ALL. 
Literature Synthesis 
Leukocyte count at diagnosis. One of the primary prognostic factors used by the 
National Cancer Institute to determine a child’s prognosis when first diagnosed with ALL is their 
leukocyte, or white blood cell, count at diagnosis (n.d.). Hyperleukocytosis, or a leukocyte count 
above the normal range of 3,500-10,500 cells/µL, has been described as an emergency situation 
within the hematological oncology field, as it has been linked to early morbidity and mortality in 
children (Mayo Foundation for Medical Education and Research, n.d.; Vaitkeviciene et al., 
2013). Children who are diagnosed with ALL and have a leukocyte count equal to or less than 
50,000 cells/µL at diagnosis are considered to be standard risk patients, while those who have a 
count of more than 50,000 cells/µL leukocytes are considered high risk patients (National Cancer 
Institute, n.d.). These interpretations were consistent with Hunger and Mulligan’s (2015) and 
Alperstein et al.’s (2015) research. Lustosa de Sousa et al. (2015) noted that patients who present 
with hyperleukocytosis when first diagnosed with ALL may also arrive with other complications, 
such as tumor masses, enlargement of the spleen and liver, and lymphadenopathy, further 
impacting the patient’s prognosis. While hyperleukocytosis at diagnosis typically indicates 
advanced disease state and a worse prognosis, strategies have been put in place to limit the 
strength of treatment, as aggressive treatment plans can cause tumor lysis syndrome and be lethal 
(Kong, Seo, Jun, Lee, & Lim, 2014). Although leukocyte count at diagnosis is one of the most 
important prognostic factors for children diagnosed with ALL, age has also been shown to have a 
strong impact on the outcomes of children with ALL. 
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Age at diagnosis. Few studies have openly discussed the significance that a child’s age at 
the time of their ALL diagnosis has on their prognosis, however, the National Cancer Institute 
(n.d.) recognizes this as one of its two primary prognostic factors. Teachey and Hunger (2013) 
described age as a strong predictor of relapse, stating that children who are diagnosed with ALL 
under the age of one year or above the age of nine years tend to have worse prognoses than 
children ages 1-9 years. Wang, Bhatia, Gomez, and Yasui (2015) later determined that children 
aged 0-1 year and 10 years and above had a much greater risk of death compared to children ages 
1-9 years. Within their study, children less than one year of age were 7.57 times more likely to 
die from ALL compared to children ages 1-9 years (Wang et al., 2015). Children 10 years and 
above did not have as great of a risk of death, but were still 4.01 times more likely to die from 
ALL compared to those ages 1-9 years (Wang et al., 2015) . Lustosa de Sousa et al.’s (2015) 
study also showed a correlation between age at diagnosis and the prognosis of that child, as 
children under the age of nine years had a five-year survival probability of 80%, compared to 
55% for children over the age of nine years (Lustosa de Sousa et al., 2015). An earlier study by 
Khalid, Moiz, Adil, and Khurshid (2010) showed that only age and immunophenotype had a 
significant influence on a child’s outcome status, although only 46 patients were included in their 
studied. They found that 78% of the children diagnosed between ages 1-9 years (n=27) had 
survived ALL for the 17-year duration of the study, compared to 0% of children under the age of 
one year (n=2) and 53% over the age of nine years (n=17) (Khalid et al., 2010). Reasons for the 
differences in survival rates based on age have been hypothesized, but few studies have 
confirmed why these differences occur. Alperstein et al. (2015) mentioned that children younger 
than one year of age typically have a very aggressive form on the disease compared to children 
above the age of one year, possibly due to the rearrangement of the MLL gene, which is 
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commonly found within these children (Wang et al., 2015). Similarly, children 10 years and 
above are also likely to have gene rearrangements associated with poor prognoses, along with 
having other unfavorable factors such as high leukocyte counts (Lustosa de Sousa et al., 2015). 
Wang et al. (2015) discussed the limited access to pediatric clinical trials seen by children over 
the age of nine years which may potentially impact the survival of this age group as well (Wang 
et al., 2015). Unfortunately, many of these hypotheses remain unstudied, leaving doctors unsure 
of why these differences occur, however it has been well documented that age at diagnosis is a 
strong predictor of outcome in ALL.  
Socioeconomic status. Although the National Cancer Institute (n.d.) only recognizes 
leukocyte count at diagnosis and age as primary prognostic factors for children with ALL, 
socioeconomic status has also been shown to be an important factor in the outcomes of these 
children. Most studies discussed socioeconomic status by means of parental education levels, 
monthly income, number of people living within one house, marital status, healthcare access, 
area remoteness, along with a few other factors that were not frequently mentioned 
(Charalampopoulou et al., 2004; Gupta, Sutradhar, et al., 2014; Petridou et al., 2015; Viana, et 
al., 1998). While it has been shown that socioeconomic status has had an impact on other disease 
outcomes, few studies have been conducted within the United States to understand the impact of 
socioeconomic status on children with ALL and their event-free survival. However, worldwide 
studies appeared to be more common, especially within developing countries. Differences in 
study outcomes were noted between the United States and other countries across the world, 
possibly due to variations in the structure of healthcare systems within these countries. Particular 
attention should be given to studies conducted within the United States as it pertains to the area 
of interest for this study. 
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United States studies. Without having a national health care system, yet being 
economically developed, the United States provides a unique perspective for the association 
between socioeconomic status and ALL outcomes. Families who are considered economically 
advantaged within the United States may not have issues getting access to treatment for their 
child with ALL, yet those who are economically disadvantaged typically do not have the same 
fate. And although treatment techniques for ALL have improved over the past few decades, a 
global meta-analysis completed by Petridou et al. (2015) found that children who were 
considered to have lower socioeconomic standing tended to be impacted by these changes in 
treatment the least. Twenty-three studies specific to ALL were included within the meta-analysis 
that assessed a variety of outcomes, such as overall survival, event-free survival, and post-relapse 
survival (Petridou et al., 2015). Researchers found that specific indicators of socioeconomic 
status, such as education, level of poverty, employment status, and household income, had a 
significant impact on overall survival (Petridou et al., 2015). Differences were noted between the 
countries included within the analysis, as studies done within the United States often saw 
discrepancies in childhood ALL outcomes between different socioeconomic groups, while other 
countries did not see these differences (Petridou et al., 2015). The following studies are the most 
recent reports that look at the association between socioeconomic status and ALL outcomes in 
children in the United States. Other studies have been conducted in previous decades, however 
changes in treatment throughout the past few decades were thought to compromise the external 
validity of those studies in comparison to today’s population.  
In a study conducted across seven different tertiary care centers within the United States, 
researchers reported an association between time to relapse and the calculated socioeconomic 
status of the patient (Bona et al., 2016). Zip codes and United States Census Bureau data were 
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utilized to create a measurement system of the socioeconomic status of a specific area, while 
information on ALL diagnosis was extrapolated from the tertiary care centers (Bona et al., 2016). 
The overall survival of children living with ALL was only 85% within high-poverty areas, 
compared to 92% for those that lived in low-poverty areas, however no difference was observed 
in event-free survival (Bona et al., 2016). However, among the studies completed within the 
United States, this study was the only one to collect data via another source besides a state cancer 
registry, possibly adding bias to the findings of this study. Those who had the means to seek 
treatment from one of the Dana-Farber Cancer Institute Consortium centers may have been more 
advantaged compared to those who did not, thus it is best to consider additional findings when 
reviewing the significance of socioeconomic status’ impact on ALL outcomes in children.  
By using the California Cancer Registry (CCR), Kent, Sender, Largent, and Anton-
Culver (2009) also completed a study on socioeconomic status’ influence on ALL outcomes. The 
study was open to those aged 0-39 years and not specified by leukemia type, different from most 
of the studies analyzed within this review. To understand the importance of socioeconomic status 
on leukemia outcomes, Kent et al. (2009) utilized the CCR’s neighborhood socioeconomic status 
variable, which was calculated using, “median educational attainment, median household 
income, proportion below 200% of the federal poverty level, median house value, median rent, 
percent employed, and proportion of the population with blue-collar employment (p. 1410).” 
Results showed that among all types of leukemia, with the exception of chronic lymphocytic 
leukemia, those living within the lowest socioeconomic quintile were shown to have a 31% 
increased risk of death compared to those living within the highest socioeconomic quintile (Kent 
et al., 2009). A similar study completed by Abrahão et al. (2015) found that children and young 
adults with ALL, aged 0-19 years, who lived within the lowest socioeconomic quintile were seen 
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to have a 39% increase in the risk of death compared to those that lived in the highest 
socioeconomic quintile. Following the conclusion of their study, Abrahão et al. (2015) 
hypothesized that these results could be due to the migrant population seen in California, as 
undocumented workers may not wish to seek medical attention for their child until they see it as 
an absolute necessity, which could lead the child to becoming much sicker in a short period of 
time. A study that looked at other high migration states found comparable results, supporting this 
hypothesis. Acharya et al. (2016) used a study population composed of children, ages 0-18 years, 
which resided in Florida or Texas. They found that those living in areas where 20-100% of the 
people lived in poverty were at 2.16 times greater risk of death compared to those living in areas 
where less than 5% of the people live in poverty, with areas having 5-20% of the population 
living in poverty having 1.36 times the risk of death compared to that same group (Acharya et 
al., 2016). As with Abrahão et al. (2015), Acharya et al. (2016) reported that more studies need 
to be conducted within the United States to support this association. Although many other studies 
have been conducted worldwide, few countries are structurally similar to the United States, 
contributing to the possibility of differences occurring among the findings of each respective 
study.  
Worldwide studies. A vast assortment of studies have been conducted worldwide to 
determine the effects of socioeconomic status upon children diagnosed with ALL. Studies 
reviewed spanned across four out of the seven continents around the world, and included 
countries such as Brazil, Canada, England/United Kingdom, Germany, Greece, Honduras, 
Scotland, South Korea, and Wales (Charalampopoulou et al., 2004; Erdmann et al., 2014; Gupta, 
Sutradhar, Guttman, Sung, & Pole, 2014; Lightfoot et al., 2012; Metzger et al., 2003; Njoku, 
Basta, Mann, McNally, & Pearce, 2013; Sergentanis et al., 2013; Son, Kim, Oh, & Kawachi, 
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2011; Viana, et al., 1998). The influence of socioeconomic status varies in each country due to 
the unique social and governmental structure found in each, providing the importance of 
studying each country individually.  
Low to middle-income countries have continued to see inferior cure rates for ALL 
compared to developed countries, as cure rates within these countries have remained near 35% 
while developed countries often see cure rates of 80% or more (Metzger et al., 2003). With only 
one treatment hospital available for all patients, Honduras often sees these reduced cure rates 
(Metzger et al., 2003). Metzger et al. (2003) tried to identify the specific reasons for these poor 
outcomes by studying children ages 0-18 years that were receiving treatment for ALL in 
Honduras. Although socioeconomic variables were not available for their study, it was discussed 
that these factors more than likely pertained to the worse outcomes seen within low- to middle-
income countries. Metzger et al. (2003) identified that the most common reason for treatment 
failure was due to treatment abandonment, possibly influenced by lack of transportation to the 
hospital, lack of parental education, or general non-compliance. A study from El Salvador found 
that maternal illiteracy, presence of a central line, and the belief that weather caused fever were 
all associated with sepsis in children diagnosed with either ALL or acute myelogenous leukemia 
(AML), further relating poor outcomes in children with leukemia to lack of parental education, a 
factor of socioeconomic status (Gavidia et al., 2012). Within Brazil, children with ALL that had 
lower socioeconomic standing had 2.51 times the risk of relapse compared to children with 
higher socioeconomic standing (Viana, et al., 1998). Viana et al. (1998) evaluated 
socioeconomic status using a questionnaire that assessed various socioeconomic factors for each 
child’s family. These factors included number of individuals living under one roof, monthly 
income for each individual in the family, general electric consumption, physical characteristics 
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of each family’s house, feeding habits of the family, sources of entertainment for the family, 
mechanisms used by the family to cope, and the family’s level of perception of leukemia (Viana, 
et al., 1998). This thorough assessment added strength to the association found between 
socioeconomic status and risk of relapse. Among the studies reviewed, Central and South 
American countries continued to struggle to have higher cure rates for leukemia compared to 
other parts of the world, more than likely due to lower socioeconomic standings among their 
citizens. However, low- and middle-income countries were not the only ones that faced these 
issues, as some developed countries have also experienced these associations as well. 
 Developed countries such as England/United Kingdom, Scotland, Wales, and Greece 
have also seen associations between socioeconomic status and various ALL outcomes among 
their children (Charalampopoulou et al., 2004; Lightfoot et al., 2012; Njoku et al., 2013; 
Sergentanis et al., 2013). Furthermore, a study including all childhood cancers in South Korea 
had similar findings (Son et al., 2011). Within this study, a birth cohort was established and 
followed for 10 years, or until death occurred (Son et al., 2011). Death from cancer was analyzed 
based on parental education and occupation found on birth certificates within the area studied 
(Son et al., 2011). After stratifying specifically for children with leukemia, parental occupation 
was the only socioeconomic variable seen to impact the mortality of the child (Son et al., 2011). 
Similar findings occurred within a study conducted within England/United Kingdom (Njoku et 
al., 2013). Njoku et al. (2013) studied socioeconomic status based upon the parental education 
reported on the birth certificates of participating individuals. After collecting data on leukemia 
(both ALL and AML) from the Northern Region Young Persons Malignant Disease Registry, 
Njoku et al. (2013) found significantly decreased rates of survival at one-year, five-years, and 
ten-years post-leukemia diagnosis. Researchers were somewhat surprised by these findings since 
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England/United Kingdom has a national healthcare system where all treatments are free for 
children diagnosed with leukemia (Njoku et al., 2013). It was hypothesized that these differences 
could be due to the challenges in gaining access to the health care provided to the country’s 
citizens (Njoku et al., 2013). Nonetheless, comparable results were also seen in a different study 
done within England/United Kingdom, which also included Scotland and Wales into its analysis 
(Lightfoot et al., 2012). Lightfoot et al. (2012) found that there was a greater risk of death at five 
years post-diagnosis for those in the lower socioeconomic quintiles compared to individuals in 
the higher socioeconomic quintiles. Although Njoku et al. (2013) and Lightfoot et al. (2012) had 
similar findings, not all studies conducted within the same country showed similar findings at the 
conclusion of their study.  
Two studies in Greece investigated the effect of socioeconomic status on ALL outcomes 
in children. Of the two studies carried out in Greece, one study used a nationwide registry 
(Nationwide Registry for Childhood Hematological Malignancies) for their study population 
while the other study used cases occurring within four Grecian hospitals across the country 
(Charalampopoulou et al., 2004; Sergentanis et al., 2013). Within the study using the nationwide 
registry, personal interviews were conducted to obtain information relating to a variety of 
sociodemographic variables (Sergentanis et al., 2013). Parental job status significantly impacted 
the outcomes of children with leukemia (either ALL or AML), as children who had parents with 
lower professional statuses were seen to have a 40% decrease in survival compared to children 
whose parents were in higher professions. Charalampopoulou et al. (2004) obtained data relating 
to socioeconomic status at the time of diagnosis, but did not find any socioeconomic status 
factors that statistically impacted survival in children with ALL. Both distance from treatment 
facility and maternal schooling were shown to be suggestive of poor survival in the children 
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studied, however were not found to be statistically significant (p = 0.08 and 0.14, respectively). 
Although the studies were completed during two different time periods (1996-2010 and 1996-
2002) and used different methods of assessing socioeconomic status, it was expected that similar 
results would be found (Charalampopoulou et al., 2004; Sergentanis et al., 2013). Nevertheless, 
the differences in association found within Greece show the importance of studying different 
areas within a country, as contrasting results can be found even in similar populations.  
 Although most of the studies reviewed found an association between socioeconomic 
status and poor outcomes for children with ALL, two studies, along with Charalampopoulou et 
al. (2014), did not observe an association. Gupta et al. (2014) studied children ages 0-18 years 
living in Ontario, Canada who were diagnosed with ALL during the years 1995-2011. 
Socioeconomic status was evaluated by using the patient’s zip code address and relating it to 
median income quintiles for that particular neighborhood (Gupta et al., 2014). No association 
between five-year event-free survival and socioeconomic status was seen after univariable and 
multivariable analysis (Gupta et al., 2014). Similarly in West Germany, family income, maternal 
education, and residential area had no influence on overall survival or event-free survival 
(Erdmann et al., 2014). Cases of ALL were established through the German Childhood Cancer 
Registry and were only included within the study if the child had been diagnosed between 
October 1992 and September 1994 and was under the age of 15 at the time of diagnosis 
(Erdmann et al., 2014). Socioeconomic status was evaluated via questionnaire or telephone 
interview (Erdmann et al., 2014). Both studies postulated that the null association they concluded 
was possibly due to the universal healthcare insurance provided to the citizens of each of the 
countries studied, as it can help to prevent the cost of treatment from interfering with adequate 
access to treatment for children with ALL (Erdmann et al., 2014; Gupta et al., 2014). 
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Unfortunately, the lack of access to treatment continues to impact the outcomes of the child with 
ALL in many other countries due to a variety of factors, including lack of health insurance and 
the location of treatment centers.  
As shown, differences in ALL outcomes based on socioeconomic status occur all over the 
world and even differ among various areas of the United States. Different areas across the United 
States and the world need to be further examined to better understand this association. It is 
important to remember that ALL is the most common type of leukemia in children, accounting 
for nearly 75-80% of all childhood leukemias, and accounts for nearly 25% of all childhood 
cancers (Lustosa de Sousa et al., 2015; National Cancer Institute, n.d.). Nevertheless, 
socioeconomic status has been shown to be influential among the outcomes of children 
diagnosed with ALL. However, health insurance, an entity relating to one’s socioeconomic 
status, may also impact ALL outcomes in children independently. 
Studies involving health insurance. A limited number of studies have examined the 
association between health insurance and leukemia outcomes. Of the studies reviewed, none 
looked exclusively at leukemia outcomes in children, and only one studied the influence of 
health insurance on patients with ALL. In the study that looked at outcomes among those with 
ALL, only young adults 18-30 years of age were assessed to understand the influence of 
insurance on overall survival (Fintel, Jamy, & Martin, 2015). Data was collected using the 
Surveillance, Epidemiology, and End Results (SEER) database between the years 2007-2010, 
and it was concluded that there was no statistical difference in the overall survival of the patients 
studied based on health insurance (Fintel et al., 2015). However, in a study looking at patients 
with AML, type of insurance was found to have an effect on overall survival (Master, Munker, 
Shi, Mills, & Shi, 2016). Within this study, the National Cancer Database was used to study 
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patients of all ages diagnosed with AML between the years 1998 and 2011 (Master et al., 2016). 
Among the 67,443 patients included in the study, those that were uninsured had a 20% increased 
risk of death from AML, while patients with Medicare or Medicaid had a 19% and 16% 
increased risk of death from AML compared to those with private insurance (Master et al., 
2016). A study completed in Puerto Rico showed similar results, as those covered by the 
government healthcare plan were at 1.6 times greater risk of death from leukemia compared to 
those covered by a non-government healthcare plan (Ortiz-Ortiz et al., 2014). However, these 
results were only seen among patients 65 years of age or older, meaning that these results do not 
necessarily apply to children (Ortiz-Ortiz et al., 2014). Nonetheless, knowledge in this area of 
study is limited, and further research in this field is needed. 
Race and ethnicity. In children with ALL, race and ethnicity have commonly been 
identified as possible prognostic factors. Numerous studies have shown that blacks, Hispanics, 
and Native Americans have worse survival rates compared to non-Hispanic white children, while 
Asian children have been shown to have differing survival rates compared to non-Hispanic white 
children (Abrahão et al., 2015; Acharya et al., 2016; Bhatia et al., 2002; Goggins & Lo, 2012; 
Hunger & Mullighan, 2015; Kadan-Lottick et al., 2003). Hunger and Mullighan (2015) stated 
within their review that these differences in survival rates might be due to the difference in the 
incidence of various genetic mutations among these races and ethnicities. For example, TCF-
3PBX1 ALL is more common in blacks, while the CRLF-2 ALL is more commonly found in 
Hispanics (Hunger & Mullighan, 2015). Thus, genetic differences may confound the impact that 
race and ethnicity have been shown to have.  
Differences in survival between non-Hispanic white children and black, Hispanic, and 
Native American children were reported within two of the studies reviewed (Bhatia et al., 2002; 
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Kadan-Lottick et al., 2003). In these same studies, Asian children were not found to have 
significantly different survival rates compared to non-Hispanic white children (Bhatia et al., 
2002; Kadan-Lottick et al., 2003). Although non-Hispanic white children were more commonly 
represented within each of these studies, this skewed population distribution was expected, as 
non-Hispanic white children tend to have higher rates of leukemia compared to other races and 
ethnicities (McCance, Huether, Brashers, & Rote, 2010). Only Kadan-Lottick et al. (2003) were 
able to capture a Native American population within their study, however the proportion of the 
sample size represented by this population was minute. Nevertheless, black and Hispanic 
children were found to be at significantly higher risk of poor outcomes in ALL compared to non-
Hispanic children within both studies, with Native American children having worse ALL 
outcomes compared to non-Hispanic white children within Kadan-Lottick et al.’s (2003) study 
(Bhatia et al., 2002). In contrast, Bhatia et al. (2002) found that Asian children were at decreased 
risk of poor outcomes compared to non-Hispanic white children, however Kadan-Lottick et al. 
(2003) reported that neither group experienced superior outcomes compared to the other. This 
difference may have been due to a larger population size utilized by Kadan-Lottick et al. (2003), 
but no other explanations for these differences could hypothesized by the researcher. Although 
both studies had relatively large sample sizes (N=4,952 in Kadan-Lottick et al. [2003] and 
N=8,447 in Bhatia et al. [2002]), the sample size for a specific race or ethnicity may have been 
small, impacting the external validity of these results. This can be seen in Kadan-Lottick et al.’s 
(2003) studying involving Native Americans, in which only 1.2% of the study population 
identified as Native Americans.  
Among the studies that did not find similar outcomes between Asian children and non-
Hispanic children, differences were still found between non-Hispanic white and black, Hispanic, 
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and where applicable, Native American children (Abrahão et al., 2015; Acharya et al., 2016; 
Goggins & Lo, 2012). Archarya et al. (2016) did not find similar outcomes between non-
Hispanic white children and Asian children since their study only compared the outcomes 
between non-Hispanic white, Hispanic, and black children. Asian and Native American children 
were excluded from their study due to low population sizes among all patients identified for their 
study (Archarya et al. (2016). Similarly, Goggins and Lo (2012) further stratified Asian children 
into the categories of East Asian (Chinese, Filipino, Korean, Japanese, Vietnamese, and other 
Southeast Asian), Other Asian, and South Asian. Therefore, each of these subpopulations had 
different findings with varying levels of significance. East Asian children were found to have an 
increased risk of poor outcomes in ALL, as were black, Native American, and Hispanic children 
when compared to non-Hispanic white children, however other Asian populations did not have 
these same findings, possibly due to the small sample population seen within these racial groups 
(Goggins & Lo, 2012). Abrahão et al. (2015) also found worse outcomes among Asian, black, 
and Hispanic children when comapred to non-Hispanic children. Black children were seen to 
have the worst outcomes of all races, having 1.78 times the risk of death compared to non-
Hispanic white children while Hispanic children were at 1.38 times greater risk and Asian 
children at 1.33 times greater risk (Abrahão et al., 2015). Even so, it can be difficult to study the 
association of ALL outcomes in children based upon race and ethinicity due to differences in the 
distribution of ALL cases among all races and ethinicities, especially when studying different 
areas across the world, thus all results should be reviewed with caution. A brief summary of all 
the racial and ethnic studies reviewed can be found in Table 1.   
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Table 1.      
Differences in ALL outcomes in children based upon race and ethnicity by research study 
 Races and Ethnicities Studied 
Authors 
African 
American/Blac
k 
Asia
n 
Non-Hispanic 
White/Caucasia
n 
Hispani
c 
  Native 
American 
Abrahão et al. (2015)  ↓ ‡ ↓ ‡ reference ↓ ‡ n/a 
Acharya et al. (2016)  ↓ ‡ n/a reference ↓ ‡ n/a 
Bhatia et al. (2002) ↓ ‡ ↑
 ‡ reference ↓ ‡ n/a 
Goggins & Lo (2012) ↓ ‡ ↑/↓  reference ↓ ‡ ↓ ‡ 
Kadan-Lottick et al. 
(2003) 
↓ ‡ (=) reference ↓ ‡ ↓ ‡ 
Note. ↓ indicates worse outcome compared to reference population; ↑ indicates better outcome 
compared to reference population; and (=) indicates similar outcome compared to reference 
population 
‡ p<0.05      
 
While a variety of studies have examined the correlation of race and ethnicity and ALL 
outcomes in children, a lack of standardization and a large variance in the number of cases 
among all races and ethnicities often makes it hard to compare these studies. A majority of the 
studies assessed showed that black and Hispanic children often had the worst outcomes among 
all races and ethnicities evaluated, with two studies finding the highest levels of risk in Native 
American children (Abrahão et al., 2015; Acharya et al., 2016; Bhatia et al., 2002; Goggins & 
Lo, 2012; Kadan-Lottick et al., 2003). It is evident that although non-Hispanic white children 
have higher rates of incidence for ALL, they often experience the best outcomes in relation to the 
disease. Numerous reasons, ranging from genetic to socioeconomic, could explain for these 
results, however limited studies have been conducted to assess these speculations. 
Sex. Many studies describe sex as having prognostic importance for childhood ALL, yet 
it remains relatively unknown to what extent. In all cancer sites, males have had higher death 
rates per 100,000 compared to females since the early 1900s (Siegel et al., 2016). And while sex 
appears to have some prognostic importance, Khalid et al. (2010) did not find a difference in 
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survival rates between males and females, ages 0-16 years, within their study. However, a 
limitation of this study was the limited amount of females (n=11) included in the study compared 
to males (n=35) (Khalid et al., 2010). Conversely, Teachey and Hunger (2013) stated within their 
review of predictors of leukemia relapse that sex does have some level of prognostic importance, 
but the extent of this importance remains undetermined. While some of this significance lies in 
the fact that the incidence rate for all types of leukemia is higher in males than females, young 
males may have worse outcomes in ALL specifically due to worse DNA indices, higher T-ALL 
incidence rates, along with other biological differences compared to females (McCance et al., 
2010; Teachey & Hunger, 2013; Wang et al., 2015). Regardless of these differences, sex is 
currently only seen to have limited prognostic value, and is generally not used to stratify the risk 
of children with ALL (Teachey & Hunger, 2013). 
Immunophenotype. Another important prognostic factor for children diagnosed with 
ALL is immunophenotype. Immunophenotype is used to describe the presence of specific cell 
molecules found on the surface of leukocytes, specifically lymphocytes in the case of ALL, in 
order to direct treatment therapies for a child or adult with ALL (Hunger & Mullighan, 2015). 
These surface molecules, otherwise known as cluster of differentiation (CD) markers, are used to 
differentiate T-cells from B-cells, and ultimately guide treatment therapy in ALL patients (Shu & 
Chen, 2005). Within children who have ALL, roughly 85% of cases are found to be of B-cell 
origin, with the other 15% having T-cell origins (Hunger & Mullighan, 2015). For a variety of 
reasons, T-cell ALL (T-ALL) has often been noted to be the least favorable type of childhood 
ALL in terms of outcome status (Alperstein et al., 2015; Hunger & Mullighan, 2015; Lustosa de 
Sousa et al., 2015; Teachey & Hunger, 2013). Hunger and Mullighan (2015) noted within their 
study that this could be because those with T-ALL tend to also be males, black, and also present 
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with higher leukocyte counts at diagnosis, along with having central nervous system involvement 
or mediastinal masses, thus already having an unfavorable prognosis. Nevertheless, patients 
diagnosed with T-ALL are subjected to more intense treatments due to its extremely aggressive 
nature (Alperstein et al., 2015). Fortunately, the differences in survival outcome between 
children who have B-cell ALL (B-ALL) and T-ALL have slowly decreased as treatments have 
improved (Teachey & Hunger, 2013). However, in children that end up relapsing, those with B-
ALL can still typically be cured, whereas relapsed T-ALL children have a very poor rates of 
three-year event-free survival, with rates typically below 15% (Teachey & Hunger, 2013). Thus, 
it is important that the diagnosis is accurate from the beginning and that treatment is adequate.  
Cytogenetics. The understanding and relative importance of the cytogenetics of a 
patient’s leukemic cells has vastly increased over the past several decades. Cytogenetic analysis 
first began back in 1956 when it was discovered that a normal human cell housed 46 
chromosomes (Harrison, 2009). As described by Harrison in 2009, the two primary 
informational pieces that physicians look at following chromosomal analysis are if there is a 
change in the number of chromosomes found within the leukemic cells or if there are changes in 
the genetic make-up of the chromosomes within these cells. Cells that contain less than 44 
chromosomes are often referred to as being “hypoploidy,” while cells containing more than 50 
chromosomes are referred to as being “hyperploidy,” (Alperstein et al., 2015). Although the 
National Cancer Institute does not currently recognize any cytogenetic abnormalities as being 
prognostic factors for relapse in those diagnosed with ALL, various authors have noted that some 
cytogenetic abnormalities have been associated with favorable or unfavorable prognosis 
(Alperstein et al., 2015; Harrison, 2009; Hunger & Mullighan, 2015; National Cancer Institute, 
n.d.; Pui, Mullighan, Evans, & Relling, 2012; Teachey & Hunger, 2013). Differences in the 
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importance in various cytogenetic abnormalities were noted within each article, however it is 
likely that new mutations were discovered throughout the years, creating these differences. 
Nonetheless, children containing hyperploidy leukemic cells, as well as cells containing a 
translocation between chromosomes 12 and 21 (creating a fusion protein known as ETV6-
RUNX1) were commonly associated with having a favorable prognosis (Alperstein et al., 2015; 
Harrison, 2009; Hunger & Mullighan, 2015; Pui et al., 2012; Teachey & Hunger, 2013). 
Children that had leukemic cells that were hypoploidy, or contained either a translocation 
between chromosomes 9 and 22 (creating the BCR-ABL1 fusion protein), an MLL rearrangement, 
or had an intrachromosomal amplification of chromosome 21 (iAMP21), were all identified as 
having unfavorable chromosomal abnormalities (Alperstein et al., 2015; Hunger & Mullighan, 
2015; Pui et al., 2012; Teachey & Hunger, 2013). Additional chromosomal abnormalities are 
currently being evaluated for their prognostic value, with current estimations of their frequencies 
and prognostic value being shown in Figure 1 (Pui et al., 2012; Teachey & Hunger, 2013). 
Treatment adherence. Although many people tend to study the overall impact of the 
factors that cannot be controlled, one factor that can often be controlled and has been shown to 
impact overall survival and event-free survival is adherence to prescribed treatment therapies. 
Treatment adherence can be influenced by socioeconomic status factors such as education and 
income, however race and ethnicity can also play contribute to the effectiveness of a treatment 
(Bhatia et al., 2012, 2014). For those diagnosed with ALL, treatment typically follows a similar 
path as depicted in Figure 2, but can differ depending on the factors discussed previously 
(Alperstein et al., 2015). Patient adherence becomes important during the maintenance phase of 
treatment, which lasts between two and three years depending on the sex of the child with ALL 
(Alperstein et al., 2015; Bhatia et al., 2012). In a study conducted by Bhatia et al. (2012), 
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adherence rates to oral mercaptopurine, a drug commonly used within the maintenance phase of 
ALL treatment, were studied in children under the age of 21 who were either of Caucasian or 
Hispanic descent. At the end of the six month study, statistical analysis was completed to see if 
there was an association between adherence rates and the risk of relapse (Bhatia et al., 2012). 
Compared to children who adhered to the medication 95% or more of the time, children adhering 
to the oral treatment only 90-94.9% of the time had four times greater risk of relapse, with those 
adhering 85-89.9% and less than 85% of the time having 3.6-5 times greater risk of relapse 
(Bhatia et al., 2012). Bhatia et al. (2014) found similar findings within a later study conducted, 
however it was also discovered that African-American and Asian-American children had more 
trouble adhering to treatment compared to Caucasian children, along with children living in low-
income households (<$50,000) compared to children living in higher-income households 
(≥$50,000). African Americans had adherence rates of 87.1% ± 2.2% and Asian Americans had 
adherence rates of 90.0% ± 2.5%, decreased from the 95.2% ± 0.6% adherence rates found in 
non-Hispanic white children (Bhatia et al., 2014). Similarly, children living in low-income 
households only had adherence rates of 89.7% ± 1.8% compared to the 95.3% ± 0.8% adherence 
rates observed in higher income households. Thus, the importance of treatment adherence should 
not be disregarded in studies that cannot obtain long-term follow-up information on treatment 
adherence within their study population. 
Summary 
 While a variety of factors have been explored within this literature review, others may 
exist in addition to those already discussed. At the present, researchers have found that 
socioeconomic status, race and ethnicity, leukocyte count at diagnosis, immunophenotype, age at 
diagnosis, and sex have shown to have an impact on the survival of children with ALL, yet 
differences in these influences have been seen among different populations. It is difficult to say 
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which factor has the largest impact on ALL survival in children, as each factor can possibly 
intertwine within another factor and increase the risk of poor outcomes in these children. In 
general, the National Cancer Institute (n.d.) stratifies children into risk groups based only upon 
leukocyte count at diagnosis and age, however as we have seen within the literature, other factors 
also play an important role in the survival of children diagnosed with ALL. 
Conclusion 
A variety of factors affecting the survival of children diagnosed with ALL have been 
introduced and examined within this literature review. Some of these variables have been well-
established as prognostic factors, however others have rarely been studied or have shown various 
levels of importance based upon the study population. For that reason, it is important to study 
specific factors, such as socioeconomic status and race and ethnicity within the West Michigan 
population of children diagnosed with ALL to establish the level of importance of these factors 
for this particular population. Other factors are important to assess for within the study, as their 
effects have shown value within other studies and should not be excluded. In the following 
chapter, the methodology of this study will be discussed in further detail, and will relate back to 
a majority of the variables discussed within this literature review. 
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Figure 1. Approximate frequency of genetic subtypes found in leukemic cells among 
children diagnosed with ALL. Blue colors indicate subtypes commonly found in children 
diagnosed with B-ALL, while red colors indicate subtypes commonly found in children 
diagnosed with T-ALL. Darker colors indicate subtypes that have been correlated with poor 
prognosis. Data for chart retrieved from Pui, Mullighan, Evans, & Relling (2012). 
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Figure 2. Standard treatment therapy progression for children with ALL. 
Image from Alperstein et al. (2015). 
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III. Methodology 
 
 Socioeconomic status has negatively influenced the outcomes of many diseases around 
the world, however its association with five-year event-free survival in children with ALL has 
not been frequently assessed within the United States. Furthermore, the association between 
socioeconomic status in the population of West Michigan children diagnosed with ALL and 
event-free survival has yet to be examined. Determining what risk factors influence five-year 
event-free survival in West Michigan children ages 0-14 years is important to add to the limited 
literature on this topic. Within this section, the overall study design for this research question, 
including study participants, data collection methods, and data analysis methods, will be 
discussed.  
Participants/subjects 
ALL accounts for roughly 26% of all cancers in children ages 0-14 years (American 
Cancer Society, n.d.). In 2013, the United States Cancer Statistics Working Group (2016) 
calculated the age-adjusted incidence rate for ALL in children ages 0-14 years to be 3.72 per 
100,000 people, the highest incidence rate among all cancers. Thus, children ages 0-14 years 
who were diagnosed with ALL between the years 2002-2011 were considered for this study. To 
restrict the chance of differences in treatment affecting any associations found, the study 
population was limited to children receiving treatment from the Helen DeVos Children’s 
Hospital’s Pediatric Hematology and Oncology program. Then, only those residing within one of 
the following Michigan counties (Allegan, Barry, Eaton, Ionia, Isabella, Kent, Lake, Mason, 
Mecosta, Montcalm, Muskegon, Newaygo, Oceana, Osceola, or Ottawa) were included in the 
study population. These counties are all supported by a nearby Spectrum Health hospital, which 
provided treatment plans set-up in coordination with the Helen DeVos Children’s Hospital 
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Pediatric Hematology and Oncology program (D. Dickens, personal communication, July 21, 
2017). Children living outside of these counties were excluded from the study population due to 
possible differences in treatment regimens.  
The choice in the years that were retrospectively analyzed was done to allow for the 
access of electronic medical records within the Spectrum Health system and a complete five-year 
analysis of those diagnosed in 2011. No data has currently been presented on the association of 
socioeconomic status and five-year event-free survival within this population, which provided 
interest for the completion of this study.  
Data Collection 
Data access to the medical records at Helen DeVos Children’s Hospital required approval 
through the Spectrum Health Institutional Review Board, Grand Valley State University’s 
Human Research Review Committee, and the permission of the Helen DeVos Children’s 
Hospital’s Pediatric Hematology and Oncology program. After approval by the above 
institutions, a list of previously identified patients diagnosed with ALL was obtained from the 
Helen DeVos Children’s Hospital’s Pediatric Hematology and Oncology program containing the 
medical record numbers (MRNs) for these patients. The list of these MRNs was created on a 
Microsoft Word file that was password protected on a password protected computer at Spectrum 
Health’s Grand Rapids location. The file was transported as a paper file within a manila envelope 
directly to the lead investigator which was then directly input into a correlation tool file within 
Microsoft Excel. The paper file was shredded immediately upon transfer of the MRNs into the 
correlation tool file. The computer file containing only the MRNs was destroyed upon transfer of 
the file to the lead investigator. 
Once the initial record of patient MRNs was input into the correlation tool file, Cerner 
Millennium (Cerner Corporation, North Kansas City, MO) electronic medical record (EMR) 
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system was utilized to complete chart reviews. Information received from the chart reviews 
included date of diagnosis, leukocyte count at diagnosis, age at diagnosis via date of birth, race, 
sex, immunophenotype, and the patient’s zip code at the present time. Date of relapse or date of 
death, whichever occurred first, was also obtained for outcome measures if applicable. Data 
viewed in Cerner Millennium was then recorded within the correlation tool file, a file that 
contained all identifiable information that remained at the hospital for security purposes, with the 
researcher being the only one able to access it if needed. Once all data had been entered into the 
correlation tool file, a new data file, or final data set, was created so that it contained no 
identifiable information. Identification numbers were used in place of identifiable MRNs, with 
zip codes and dates of birth also being deidentified and removed from the new data file. The 
correlation tool file was destroyed following the completion of the research study. The final data 
set file to be stored following the completion of the study contained only de-identified 
information. All files utilized for data collection purposes were password protected along with 
being secured through a password protected computer. In addition to this, the correlation tool file 
and final data set file were saved onto separate computers as well.  
Data Analysis 
Prior to starting statistical analysis, data obtained during data collection were deidentified 
and recoded into categorical variables. The MRN for each patient was recoded starting from a 
value of 0001 for the first patient, followed by subsequent numbers until all MRNs had been 
recoded. Date of birth was used to identify what age the child was when they were diagnosed 
with ALL, but then further recoded into age categories. Age at diagnosis was categorized into the 
following categories: 1-4 years, 5-9 years, and ≥10 years of age. The categorization of race was 
dependent on the distribution of the sample collected, thus categorization of the data fell into just 
two groups: Caucasian and Other. 
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United States Census information from 2000 was used to create a neighborhood 
socioeconomic score for each child’s particular zip code based on the calculation utilized by 
Diez Roux et al. (2001). The score encompassed three main areas connected with socioeconomic 
status: education, income, and occupation. Data from the 2000 United States Census used for the 
calculation of each neighborhood socioeconomic score based on each individual’s zip code 
included median household income (log value), median value of housing units (log value), 
percentage of households receiving interest, dividend, or net rental income, percentage of adults 
25 years of age or older who had completed high school, percentage of adults 25 years of age or 
older who had completed a college (bachelor’s) degree, and the percentage of employed persons 
16 years of age or older in executive, managerial, or professional specialty occupations (Diez 
Roux et al., 2001). Once all areas were assessed for each individual, z-scores for each variable 
used within the neighborhood socioeconomic score were calculated by subtracting the mean 
from the value of the variable and then dividing by the standard deviation. The z-score 
represented the amount of deviations from the mean. For example, a calculated z-score value of 
3.0 for the variable “percentage of households receiving interest, dividend, or net rental income 
means” for that specific zip code shows that the Census value is three standard deviations above 
the mean for all values obtained for that variable. Similarly, a z-score of -3.0 means the value is 
three standard deviations below the mean value. Once all z-scores were calculated, individual 
neighborhood socioeconomic scores were created by adding all z-scores from each variable 
specific to that child’s zip code. For instance, if a child had z-scores of 1.9, 2.3, -1.2, 1.0, and 
3.2, the neighborhood socioeconomic score for that child was equal to 7.2. Increasing scores 
signified increased advantage among the neighborhood. Scores were stratified into three 
socioeconomic groups (lowest, middle, and highest) based upon their standing among the other 
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values, with the lowest third of scores being coded as the lowest socioeconomic group, and so 
on. These scores were linked to the initial zip code recorded for each patient prior to the zip code 
being removed. 
Descriptive statistics were utilized to reflect the distribution of the predictive factors 
collected based upon the socioeconomic tertiles created. Frequency and percent were reported 
for categorical variables and mean (SD) for continuous variables. Five-year event-free survival 
was assessed based on either relapse to any type of cancer or death for each child included in the 
study. Differences in survival for each socioeconomic tertile were evaluated via Kaplan-Meier 
survival analysis, generating Kaplan-Meier survival plots. Cox proportional hazard models were 
conducted to explore the association between all factors studied. The initial unadjusted model 
assessed the risk of relapse or death between the neighborhood socioeconomic tertiles created, 
which was then adjusted for age, race, and sex. A final model included the additional adjustment 
of leukocyte count at diagnosis and immunophenotype. Hazard ratios were calculated to 
understand the risk of relapse or death between the various neighborhood socioeconomic tertiles. 
The assumptions for proportional hazards were tested and were met. SAS 9.4 (SAS Institute, 
Inc., Cary, NC) was used for all statistical analysis.  
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IV. Results 
 
During the investigation period between the years 2002-2011, 133 patients sought care 
for ALL at the institution of interest. Twenty-one subjects did not meet inclusion criteria due to 
residing outside of the selected study area. Among the 112 eligible subjects, eight were excluded 
due to having missing information for age at diagnosis, leukocyte count at diagnosis, event 
status, or a combination of these three variables. One additional individual was excluded from 
the study population due to a lack of available information of their socioeconomic status, leaving 
a total of 103 subjects to be utilized for data analysis. Figure 3 displays a flow diagram of the 
exclusionary process among study subjects from the beginning of data collection for the time 
period of interest to the time of data analysis.  
133 Total Subjects 
Investigated 
21 subjects excluded 
for being outside of 
study zone 
N=112 
8 subjects excluded for 
lack of available data 
(age, WBC count, or 
event status) 
N=104 
1 subject excluded due 
to missing SES data 
103 Subjects Utilized 
for Data Analysis 
Figure 3. Flow diagram of subject inclusion during the study period of 
interest from the beginning of data collection to the time of data analysis. 
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Descriptive Statistics 
Among the 103 study participants that were included within the data analyses, 61.2% 
were male. Mean age at diagnosis was almost six years (M = 5.91, SD = 3.71) with a median of 
five years (IQR=6.00). Age was later categorized into three different categories, ages 1-4 years, 
5-9 years, and ≥10 years, with most of the population falling into the age range of 1-4 years 
(46.6%). The study population primarily identified as being Caucasian (80.6%) and was most 
commonly diagnosed with B-ALL (84.5%). A full summary of the descriptive characteristics of 
the study population can be found in Table 2. Following the calculation of the neighborhood 
socioeconomic scores, the mean score of the population was 0.18 (M = 0.18, SD = 4.75), with a 
median score of -0.11 (IQR = 8.02). Neighborhood socioeconomic scores ranged from -8.61 to 
15.9. 
Table 2.
Demographic Variable N (%) M (SD)
Age at diagnosis (years) 5.91 (3.71)
1-4 48 (46.7%)
5-9 32 (31.1%)
10+ 23 (22.3%)
Sex
Male 63 (61.2%)
Female 40 (38.8%)
Race
White 83 (80.6%)
Hispanic 12 (11.7%)
Other 8 (7.8%)
Immunophenotype
B-ALL 87 (84.5%)
T-ALL 15 (14.6%)
Missing 1 (1.0%)
Leukocyte count at diagnosis (x10
9
/L) 36.8 (39.2)
Descriptive statistics for the 103 eligible ALL cases from 2002-2011
Note.  Based on 103 study subjects utilized for data analysis. B-ALL= B-
cell acute lymphoblastic leukemia; T-ALL = T-cell acute lymphoblastic 
leukemia
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Survival Analyses 
During the five-year follow-up period in which subjects were assessed, a total of eleven 
participants (10.7%) experienced an event, defined as either relapsing into any form of cancer or 
death. All events that were recorded were relapses, with one death occurring after an initial 
relapse. Among the subjects that experienced an event, two subjects were from the lowest 
neighborhood socioeconomic tertile, with the middle tertile having three children experience an 
event, and the highest tertile having six children that experienced an event. Kaplan-Meier 
survival analysis did not show a difference in survival between the different socioeconomic 
tertiles assessed, χ2 (2, N = 103) = 2.70, p = 0.26, as demonstrated by Figure 4. 
Three sequential Cox Proportional Hazards models were conducted for this study. The 
proportional hazards assumption was checked and met for the initial unadjusted model. The 
results for this assumption can be found in the Appendix. In the initial unadjusted Cox 
Proportional Hazards model, the risk of relapsing or dying within five years varied across the 
tertiles of socioeconomic scores, however these differences did not prove to be statistically 
significant. Children who were categorized as being within the middle tertile saw a 1.48 times 
greater risk of relapsing or dying within five years of their diagnosis compared to children of the 
lowest tertile (HR = 1.48, p = 0.67, 95% CI [0.25, 8.86]), while children who were categorized as 
being within the highest, or most affluent, tertile had a 3.17 times greater risk of relapse or death 
within five years compared to children who were categorized as being within the lowest 
socioeconomic tertile (HR = 3.17, p = 0.16, 95% CI [0.64, 15.7]).  
When adjusting for the demographic variables age, race, and sex, the association between 
neighborhood socioeconomic score and relapse or death attenuated. Children that were in the 
middle tertile of the calculated neighborhood socioeconomic scores had a 1.26 times greater risk 
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of relapsing or dying within five years after adjusting for age, race, and sex (HR = 1.26, p = 0.81, 
95% CI [0.19, 8.33]) compared to children in the lowest tertile. Children categorized into the 
highest tertile were at 3.02 times greater risk of having an event within five years after adjusting 
for age, race, and sex as well (HR = 3.02, p = 0.19, 95% CI [0.59, 15.5]) compared to children in 
the lowest tertile. However, neither of these associations reached the threshold for statistical 
significance. Among the demographic variables analyzed and adjusted within the model, 
children above the age of four-years, non-whites, and males were all at greater risk of 
experiencing an event within five years of their diagnosis compared to their counterparts, 
however none of these results were statistically significant (Table 3).  
The final, full model contained all the variables collected for the study: neighborhood 
socioeconomic scores, age, race, sex, leukocyte count at diagnosis, and immunophenotype. After 
adjusting for these variables, the association between neighborhood socioeconomic status and 
relapse or death further attenuated. Similar to the previous models explored, when compared to 
the lowest socioeconomic tertile, both the middle tertile, and the highest tertile had a greater risk 
of relapsing or dying within five years of the initial diagnosis. The middle tertile saw a 1.27 
times greater risk of having an event within five years of diagnosis (HR = 1.27, p = 0.80, 95% CI 
[0.19, 8.48]), while the highest tertile saw a 2.95 times greater risk within five years (HR = 2.95, 
p = 0.20, 95% CI [0.57, 15.3]), when adjusting for all the variables included within the full 
model. In addition to these findings, children over the age of four-years, non-whites, males, and 
those diagnosed with B-ALL were all found to have a greater risk of relapsing or dying within 
five years compared to their counterparts. None of these findings proved to be statistically 
significant, however. Table 3 contains the full results from each of the respective Cox 
Proportional Hazards models discussed above. 
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Figure 4. Kaplan-Meier estimates of five-year event-free survival for children diagnosed with 
ALL by calculated neighborhood socioeconomic score tertiles. Log-rank test of homogeneity: 
χ2 = 2.70, p = 0.26. Blue numbers indicate the number of children within the lowest 
socioeconomic tertile who did not have an event (event-free survival) at each point in time, 
with red numbers being indicative of event-free survival within the middle socioeconomic 
tertile and green numbers being indicative of event-free survival in the highest socioeconomic 
tertile. 
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V. Discussion 
 
A difference in five-year event-free survival was not detected between those of lower 
socioeconomic standing and those of higher socioeconomic standing when studying children, 
ages 0-14 years, who were diagnosed with ALL within West Michigan. While many studies have 
previously shown that those of lower socioeconomic standing are more likely to have worse 
health outcomes for a variety of health issues, little research has been done to describe this 
association among those diagnosed with ALL, especially within children (Demakakos et al., 
2008). This study was one of the few to look at this association among children diagnosed with 
ALL in the United States, and the first to try and understand the association within the West 
Michigan area. Those of higher socioeconomic standing within the population under 
investigation were found to have a greater risk of relapsing or dying within five years of their 
initial ALL diagnosis, but not statistically. These results differ from previous studies conducted 
in the United States, which found protective effects of the higher socioeconomic class (Abrahão 
et al., 2015; Bona et al., 2016; Kent et al., 2009; Petridou et al., 2015). The differences in these 
findings suggest that more research within this field should continue to be conducted to better 
understand the association of interest.  
 Finding that patients from higher socioeconomic neighborhoods were more likely to 
experience relapse or death compared to those of living within lower socioeconomic 
neighborhoods was contrary to the original hypothesis. Although unanticipated, the results of this 
study add to the limited current literature, especially within the United States. The study was able 
to assess for a multitude of possible confounding variables, increasing the ability to understand 
the true association between socioeconomic status and five-year event-free survival among the 
population of interest. And while the small sample size (N=103) likely contributed to an 
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underpowered study, the results can further the discussion between the association of 
socioeconomic status and health-related outcomes, especially among those diagnosed with ALL. 
Prior to the start of data analysis, it was initially hypothesized that those of lower socioeconomic 
standing would be more likely to experience relapse or death, as those of higher socioeconomic 
status tend to have better overall health and health outcomes, compared to those of lower 
socioeconomic standing (Lynch et al., 2004). However, in 1997, Greaves described that 
advances in hygiene and changes to the typical contact children had with one another via day-
care, particularly among those of higher socioeconomic status, may contribute to decreased 
exposure to early childhood infectious agents. This decreased exposure to infectious agents may 
leave children to be more at risk for diseases such as ALL due to the lack of immune system 
regulation during the child’s early childhood years. In addition to this, it was hypothesized that 
mothers living in developed areas may be less likely to pass on immunity to their newborn child 
if they were not exposed to various infectious agents prior to, or during the pregnancy (Greaves, 
1997). A case-control study utilizing data from the CCR, along with another case-control study 
using data collected around the world, were able to support the hypothesis that early childhood 
infections may be able to protect individuals from developing ALL (Marcotte, Ritz, Cockburn, 
Yu, & Heck, 2014; Rudant et al., 2015). These studies were able to look at a variety of variables 
related to early childhood exposure to infections, further helping to support the hypothesis 
discussed by Greaves (1997) and the findings of our study.  
In the study completed by Rudant et al. (2015), researchers tried to gain an understanding 
of the effects of breastfeeding, day care attendance, and birth order on the risk of a child 
developing ALL (Rudant et al., 2015). It was found that breastfeeding for six months or longer, 
higher birth order, and day-care attendance within the first year of life all had a protective effect 
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against the development of ALL in children, likely due to the increased immunity provided by 
the mother during breastfeeding and due to the increased exposure to infectious agents via 
siblings and other children (Rudant et al., 2015). Marcotte et al. (2014) also looked at various 
markers related to the possibility of exposure to infections and risk of ALL later in life. Variables 
analyzed within Marcotte et al.’s (2014) large case-control study included birth month, birth 
order, and the time of birth in comparison to influenza and common respiratory virus cycles. It 
was determined that those born during the spring and summer months, and those exposed to the 
common childhood viruses later in life, were at increased risk of developing ALL (Marcotte et 
al., 2014). Birth order also appeared to be a protective factor when looking at the risk of the 
development of ALL, as there was a decreased risk of ALL among those higher within their 
family’s birth order (Marcotte et al., 2014). This is likely due to the fact that as a child is born 
higher into the birth order, a child is exposed to more infectious agents from his or her siblings 
born before him or her. Nonetheless, the findings seen within the studies completed by Marcotte 
et al. (2014) and Rudant et al. (2015) support the early hypothesis created by Greaves (1997) that 
early childhood exposures to infectious agents may reduce the risk of a child getting ALL. These 
studies, along with future research within this area, may help to explain why children of higher 
socioeconomic status may be at greater risk of relapsing or dying compared to children with 
lower socioeconomic backgrounds.  
Strengths  
 The overall design of the study helped to create several strengths. By identifying the 
location of all the hospitals within the Spectrum Health organization, it was possible to limit the 
study population to only counties located near a Spectrum Health facility, limiting the chance 
that an individual may seek treatment at a facility other than Spectrum Health during the study 
period. This also led to better retention and tracking of the patients included within the study and 
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helped to limit travel distance to treatment facility as a potential confounder. Furthermore, the 
sampling method utilized within the study allowed for a population that was distributed similar 
to previous studies that had been completed. Hunger and Mullighan (2015) noted that more 
males tended to be diagnosed with ALL compared to females (male to female ratio of 55% to 
45%), similar to the ratio found within the study (61% males, 39% females). The distribution of 
the various races observed within the study was similar to the much larger study (N=14,192) 
completed by Hossain, Xie, and Mccahan (2014), as 83% of children within their study were 
Caucasian, compared to the 81% of children identified as being Caucasian within this study. 
After further discussion of the population utilized for the study, it was determined that the study 
was also distributed as expected by the doctors within the Helen DeVos Children’s Hospital’s 
Pediatric Hematology and Oncology program (D. Dickens, personal communication, July 21, 
2017). Along with the strengths listed above, the short time period of interest allowed for fewer 
changes in the treatment protocol to occur over the study period, further limiting the chance that 
changes in treatment could have been a confounder within the study.   
Limitations    
 With fewer subjects eligible for the study than previously expected, the limited sample 
size (N = 103) available for statistical analysis largely impacted the power to detect statistically 
significant findings. The lack of events that occurred within the population, although showing 
positive outcomes for those diagnosed with ALL, may have also contributed to the lack of an 
observed association between neighborhood socioeconomic scores and event-free survival in 
children diagnosed with ALL. The small sample size also limited the power available to be able 
to explore possible interactions between various variables collected during the data collection 
process. As discussed by Vanderweele and Knol (2014), in order to look into the interaction 
between various variables included within the study, a larger sample size would be necessary.  
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 Individual-level socioeconomic status information was not obtained from each child 
included within the study, however the neighborhood socioeconomic score used to look at the 
association of interest has been shown to be predictive of various health-related outcomes, even 
after controlling for individual and family-level socioeconomic status (Chen & Paterson, 2006). 
Individual-level insurance status was also not able to be obtained during the final data analysis 
due to inconsistent reporting within the medical record. Individual treatment plans were also 
unable to be viewed, leaving the possibility for selection bias in who sought care at Spectrum 
Health, to influence the results. Lastly, the impact of genetic mutations within the leukemic cells 
found in each patient could not be assessed for, as information regarding the genetic analysis of 
the leukemic cells could not be uniformly obtained for all individuals included within the study. 
In addition to this, cytogenetic analysis has improved and changed throughout the years under 
investigation within this study, thus comparing each patient’s cytogenetics using the same 
threshold would be unclear, as there were changes in the testing and reporting of these genetic 
factors during the study period.  
Recommendations for Practice 
 As the survival rate for those diagnosed with ALL has risen from below 10% during the 
1960s, to roughly 90% over the past several decades, changes in the relative treatment of the 
disease are not a necessity, however it is important to continue to address the impacts of 
treatment inequalities (Lustosa de Sousa et al., 2015; Nguyen et al., 2008; Wang et al., 2015). 
Petridou et al. (2015) found within their meta-analysis that although improvements have been 
made in the treatment of ALL, those within lower socioeconomic settings are less likely to be 
able to take advantage of these improvements. However, improvements in caring for those of 
lower socioeconomic status continue to be made in the healthcare setting, as various hospitals are 
incorporating the use of social workers and other faculty members to better facilitate an open line 
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of communication between physicians and families, along with addressing additional needs 
certain families might have. Currently, Spectrum Health’s Helen DeVos Children’s Hospital’s 
Pediatric Hematology and Oncology programs is able to help provide transportation and support 
the payment of co-pays for various individuals who seek treatment within their clinic, helping to 
decrease the chance that socioeconomic status may lead to different ALL outcomes (personal 
communication, D. Dickens, July 21, 2017). Additional improvements within the practice, such 
as strictly enforcing medication adherence, ensuring that follow-up care is completed, and the 
quick identification of new possible ALL cases, have also helped to limit and potentially 
overcome differences between the various socioeconomic groups that exist (personal 
communication, D. Dickens, July 21, 2017). The further development of such practices may lead 
to hospital systems being able to overcome socioeconomic status disparities seen in many health 
outcomes.   
In addition to the improvements described above, the state of Michigan continues to fund 
the “Children’s Special Health Care Services” program, as those diagnosed with roughly 2,700 
severe diseases, such as ALL, are eligible to receive financial assistance regardless of 
socioeconomic status as long as the child is a resident of the state of Michigan and under the age 
of 21 (Michigan Department of Health and Human Services, 2017). Nonetheless, while 
improvements in the care of all socioeconomic backgrounds have been made via policies and 
healthcare practices, it is imperative that continual research be conducted to better understand the 
association between socioeconomic status and relapse and/or death in children diagnosed with 
ALL. Limited research still exists across the United States for public health officials to be able to 
understand the true impact of socioeconomic status on ALL outcomes. It may also be of interest 
to further investigate the impacts that improved hygiene and changes to childcare have had on 
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various immune-mediated diseases, such as ALL, as this field of research may explain why those 
of higher socioeconomic standing were at greater risk of relapse within our study. With many 
major healthcare services already in place for those of all socioeconomic backgrounds, the 
continuation and adaptation of these services to better meet the needs of all levels of wealth is 
important to improve the health of children diagnosed with ALL.  
Future Directions  
 While the association of interest did not prove to be statistically significant, changes 
within the methodology of this study can be made to improve the statistical power of a future 
study. It is proposed that by gaining a larger population to study, possibly by sampling all 
children within the state of Michigan, ages 0-14 years, who were diagnosed with ALL, a better 
understanding of the research question under investigation can be gained. This can be completed 
by working with other hospital systems across the state, or by utilizing data collected by the 
Michigan Cancer Surveillance Program. However, differences in treatment may occur across the 
state, potentially confounding the association of interest. It may also be difficult to accurately 
assess for socioeconomic status depending on the method chosen from those described above, 
thus it is important to explore both avenues of study adequately. Nevertheless, the research 
question of interest for this study has been understudied within the United States, thus the 
completion of a larger study would greatly benefit those researching, treating, or undergoing 
treatment within the pediatric ALL community.  
 It would also be advantageous for future research to look further into the differences in 
event-free survival based on socioeconomic status in other areas of the United States, as each 
area has different racial compositions and hospital system availability compared to West 
Michigan. Currently, one of the Office of Disease Prevention and Health Promotion's (2014) 
Healthy People 2020 goals is to achieve equality in its medical care for all people, as the Agency 
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for Healthcare Research and Quality (AHRQ) (2014) still reports differences in the quality of 
healthcare received by different racial groups. Additionally, Horwitz (2005) discussed how 
different types of hospitals, specifically for-profit compared to non-profit, often have differences 
in the services and quality of services they provide. With many areas across the United States 
having different racial compositions and hospital systems compared to that of West Michigan, it 
is important to understand how these differences may affect ALL outcomes. The AHRQ reported 
in 2014 that although improvements in treating disparities among minority populations has 
improved, access and quality of care remain issues for many minorities. Language barriers and 
healthcare insurance status were reported as major barriers for many minorities in gaining access 
to care, however the predominately non-Hispanic white population seen within West Michigan 
may not see these barriers compared to other areas around the United States that are composed 
primarily of minority races (AHRQ, 2014). Similarly, for-profit hospitals have been shown to be 
less likely to provide services that are not profitable compared to their counterparts, even if the 
need for that service is evident within the community (Horwitz, 2005). Private hospitals also 
tended to serve higher-income individuals compared to those that have lower socioeconomic 
standing, possibly suggesting that there may be a difference in who is more likely to seek 
treatment at a specific health institution (Basu, Andrews, Kishore, Panjabi, & Stuckler, 2012). 
Thus, future research should further investigate other areas of interest across the United States, 
especially ones that are composed of different racial groups and hospital systems compared to 
those seen here in West Michigan. 
 In addition to the suggestions given above, following the discussion of the study’s 
findings, it would be beneficial to continue the investigation on the impact of early infectious 
disease exposures on the risk of developing ALL and/or relapsing or dying from the disease once 
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diagnosed. The studies that have been completed within this context of study have shown 
promising results, similar to those investigating the importance of socioeconomic status in 
identifying those who may relapse or die from ALL, however a limited number of studies have 
been completed within this field of research. Looking further into the association between early 
childhood infectious exposures and the development of ALL may help to identify new risk 
factors for the development of this disease or risk factors for possible relapse or death among 
those already diagnosed. As improvements in hygiene and changes to childcare continue to 
occur, the need for ongoing research in this field is important for those who are diagnosed with 
ALL, may become diagnosed with ALL, along with others who may suffer from other immune-
mediated diseases.   
Conclusions 
 The results of this study show that there is a need to continue the research efforts being 
put forth to look at the association of socioeconomic status and event-free survival in children 
diagnosed with ALL, particularly within the United States. Our study showed that children living 
in areas of greater socioeconomic status may be more likely to experience either a relapse or 
death from their ALL compared to children of lower socioeconomic status, differing from the 
results observed within other studies completed within the United States (Abrahão et al., 2015; 
Bona et al., 2016; Kent et al., 2009; Petridou et al., 2015). These differences may be able to be 
explained by decreases in early childhood exposure to infectious agents caused by improvements 
in hygiene and changes in childcare over the years. Further research should be conducted in 
looking at the association between socioeconomic status and event-free survival in children 
diagnosed with ALL, along with exploring other relevant areas mentioned previously. It is 
important to continue research in this field, as well as in other areas of healthcare research, in 
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order to decrease the differences observed between the health outcomes of the various 
socioeconomic backgrounds that exist. 
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